Literature DB >> 8386567

Epstein-Barr virus and carcinomas.

G Niedobitek1, H Herbst, L S Young.   

Abstract

The Epstein-Barr virus, a human B lymphotropic herpes virus, is strongly associated with undifferentiated nasopharyngeal carcinoma, which is endemic in Southern China and North Africa. More recently, an association of the virus with certain other epithelial malignancies has been described, some of which are more common in Western countries. Also, the observation that oral hairy leukoplakia, an acquired immunodeficiency syndrome-related lesion of the tongue, supports Epstein-Barr virus replication in the epithelial cell compartment has further strengthened the notion that Epstein-Barr virus infection of epithelial cells may be an important phenomenon in vivo. The purpose of this article is to review the association of Epstein-Barr virus with nasopharyngeal carcinomas, to examine the evidence suggesting an association of the virus with other epithelial neoplasias and to discuss Epstein-Barr virus infection of non-neoplastic epithelial cells.

Entities:  

Mesh:

Year:  1993        PMID: 8386567     DOI: 10.1007/bf02592275

Source DB:  PubMed          Journal:  Int J Clin Lab Res        ISSN: 0940-5437


  3 in total

1.  The high frequency of EBV infection in pediatric Hodgkin lymphoma is related to the classical type in Bahia, Brazil.

Authors:  Iguaracyra Araujo; Achiléa Lisboa Bittencourt; Helenemarie S Barbosa; Eduardo Martins Netto; Núbia Mendonça; Hans-Dieter Foss; Michael Hummel; Harald Stein
Journal:  Virchows Arch       Date:  2006-08-01       Impact factor: 4.064

2.  Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity.

Authors:  R Fåhraeus; L Palmqvist; A Nerdstedt; S Farzad; L Rymo; S Laín
Journal:  EMBO J       Date:  1994-12-15       Impact factor: 11.598

3.  Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas.

Authors:  D C Rowlands; M Ito; D C Mangham; G Reynolds; H Herbst; M T Hallissey; J W Fielding; K M Newbold; E L Jones; L S Young
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.